פינק ביסמוט תרחיף Ισραήλ - Εβραϊκά - Ministry of Health

פינק ביסמוט תרחיף

perrigo israel agencies ltd, israel - bismuth sub salicylate - תרחיף - bismuth sub salicylate 262.50 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

פפטולייט תרחיף Ισραήλ - Εβραϊκά - Ministry of Health

פפטולייט תרחיף

perrigo israel agencies ltd, israel - bismuth sub salicylate - תרחיף - bismuth sub salicylate 262.5 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

פפטולייט טבליות לעיסה Ισραήλ - Εβραϊκά - Ministry of Health

פפטולייט טבליות לעיסה

perrigo israel agencies ltd, israel - bismuth subsalicylate - טבליות לעיסות - bismuth subsalicylate 262 mg - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

פפטולייט טבליות לעיסה Ισραήλ - Εβραϊκά - Ministry of Health

פפטולייט טבליות לעיסה

perrigo israel agencies ltd, israel - bismuth subsalicylate - טבליות לעיסות - bismuth subsalicylate 262 mg - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

פוסאוונס 70מג5600 יחבל טבליות Ισραήλ - Εβραϊκά - Ministry of Health

פוסאוונס 70מג5600 יחבל טבליות

merck sharp & dohme israel ltd - alendronic acid as alendronate sodium trihydrate; colecalciferol - טבליה - colecalciferol 140 mcg; alendronic acid as alendronate sodium trihydrate 70 mg - colecalciferol - colecalciferol - fosavance is indicated for : treatment of osteoporosis in postmenopausal women: for the treatment of osteoporosis, fosavance increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). treatment to increase bone mass in men with osteoporosis.

קלצימור Ισραήλ - Εβραϊκά - Ministry of Health

קלצימור

taro pharmaceutical industries ltd - calcium carbonate - טבליות לעיסות - calcium carbonate 600 mg - calcium carbonate - calcium carbonate - antacid, calcium deficiency.

סבוסל Ισραήλ - Εβραϊκά - Ministry of Health

סבוסל

taro pharmaceutical industries ltd - selenium sulfide - תרחיף - selenium sulfide 25 mg/ml - selenium sulfide - selenium sulfide - for the treatment of dandruff, seborrheic dermatitis of the scalp and tinea versicolor.

זובירקס טבליות 400 מג Ισραήλ - Εβραϊκά - Ministry of Health

זובירקס טבליות 400 מג

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including intial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

זובירקס טבליות 200 מג Ισραήλ - Εβραϊκά - Ministry of Health

זובירקס טבליות 200 מג

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

זובירקס טבליות מסיסות 800 מג Ισραήλ - Εβραϊκά - Ministry of Health

זובירקס טבליות מסיסות 800 מג

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.